Comparison of Safety, Effectiveness and Quality of Life Outcomes Between Labeled Versus "Treat and Extend" Regimen in Turkish Patients With Choroidal Neovascularisation Due to Age-related Macular Degeneration (AMD)
Conditions
- Age-related Macular Degeneration
Interventions
Sponsor
Novartis Pharmaceuticals